Sientra reports rising revenue, declining losses
Goleta-based Sientra reported record revenue for the fourth quarter and full year of 2021, and while the company still saw net losses, they were lower, the company reported March 23. Sientra, a breast implant manufacturer, had revenue of $22.6 million for the quarter, representing growth of 26.6% year-over-year, excluding discontinued operations. For the full year, Read More →
Cottage files suit against Kaiser seeking ‘tens of millions’
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
At Westmont breakfast, author Michael Lewis talks of Santa Barbara’s ‘superhero of communicable disease’
On March 6, 2020, Westmont College held its annual President’s Breakfast, which would be one of the last large indoor, public events in the region before the COVID-19 pandemic arrived. The guest was Nobel-winning psychologist and economist Daniel Kahneman. This year on March 4, at the event’s return to the Hilton Santa Barbara Beachfront Resort, Read More →
MannKind shares at lowest since 2020 after earnings report
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Arcutis share up after earnings report; company reports mounting losses but progress toward FDA approval
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Inogen shares up after earnings report, despite growing losses
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Atara reports patient death in cancer treatment study
Atara Biotherapeutics, a South San Francisco-based drug development company with major operations in Thousand Oaks, reported to the U.S. Food and Drug Administration on Feb. 18 that a patient died in one of its Phase 1 trials. The patient, who was being treated at a Memorial Sloan Kettering Cancer Center location in New York, suffered Read More →
